Drug recall
Diltiazem Hydrochloride Extended-Release Capsules, USP, 120 mg, 90 count bottle, Rx only, Manufactured for…
FDA recall event 29846 · Class III · Biovail Laboratories, Inc.
Key facts
| Event ID | 29846 |
|---|---|
| Recall numbers | D-045-5, D-046-5, D-047-5 |
| Recalling firm | Biovail Laboratories, Inc. |
| Product type | Drugs |
| Products | Diltiazem Hydrochloride Extended-Release Capsules, USP, 120 mg, 90 count bottle, Rx only, Manufactured for: Teva Pharmaceuticals, Sellersville, PA, Manufactured by: Biovail Corporation International…, Diltiazem Hydrochloride Extended-Release Capsules, USP, 180 mg, 90 count bottle, Rx only, Manufactured for Inwood Laboratories Inc., Inwood, NY, By Biovail Corporation, Mississauga, Ontario, Canada…, Diltiazem Hydrochloride Extended-Release Capsules, USP, 300 mg, 90 count bottle, Rx only, Manufactured for Inwood Laboratories Inc., Inwood, NY, By Biovail Corporation, Mississauga, Ontario, Canada… |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Dissolution Failure |
| Initiation date | Aug 11, 2004 |
| City | Carolina |
| Country | United States |
| FEI number | 2650179 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports